vs

Side-by-side financial comparison of CKX LANDS, INC. (CKX) and Pluri Inc. (PLUR). Click either name above to swap in a different company.

Pluri Inc. is the larger business by last-quarter revenue ($398.0K vs $232.6K, roughly 1.7× CKX LANDS, INC.). On growth, Pluri Inc. posted the faster year-over-year revenue change (314.6% vs 35.8%). Over the past eight quarters, Pluri Inc.'s revenue compounded faster (171.5% CAGR vs -42.0%).

CKX Lands, Inc. is a U.S.-based land management and natural resources company. It owns and manages land parcels across North America, with core business segments including timber production, mineral rights leasing, agricultural land rental, and recreational land access services for individual and commercial customers.

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

CKX vs PLUR — Head-to-Head

Bigger by revenue
PLUR
PLUR
1.7× larger
PLUR
$398.0K
$232.6K
CKX
Growing faster (revenue YoY)
PLUR
PLUR
+278.8% gap
PLUR
314.6%
35.8%
CKX
Faster 2-yr revenue CAGR
PLUR
PLUR
Annualised
PLUR
171.5%
-42.0%
CKX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CKX
CKX
PLUR
PLUR
Revenue
$232.6K
$398.0K
Net Profit
$166.3K
Gross Margin
52.0%
Operating Margin
48.7%
Net Margin
71.5%
Revenue YoY
35.8%
314.6%
Net Profit YoY
207.3%
-32.6%
EPS (diluted)
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CKX
CKX
PLUR
PLUR
Q3 25
$232.6K
Q2 25
$135.9K
$398.0K
Q1 25
$348.2K
$427.0K
Q4 24
$180.6K
$185.0K
Q3 24
$171.3K
$326.0K
Q2 24
$1.0M
$96.0K
Q1 24
$141.8K
$71.0K
Q4 23
$690.4K
$105.0K
Net Profit
CKX
CKX
PLUR
PLUR
Q3 25
$166.3K
Q2 25
$161.0K
Q1 25
$115.6K
$-6.1M
Q4 24
$-3.0M
Q3 24
$54.1K
$-5.9M
Q2 24
$565.3K
Q1 24
$-401.3K
$-5.3M
Q4 23
$-4.9M
Gross Margin
CKX
CKX
PLUR
PLUR
Q3 25
Q2 25
52.0%
Q1 25
31.9%
Q4 24
60.0%
Q3 24
61.3%
Q2 24
95.8%
Q1 24
100.0%
Q4 23
100.0%
Operating Margin
CKX
CKX
PLUR
PLUR
Q3 25
48.7%
Q2 25
Q1 25
32.2%
-1264.6%
Q4 24
-41.9%
-2679.5%
Q3 24
-9.9%
-1594.5%
Q2 24
62.9%
Q1 24
-307.8%
-7794.4%
Q4 23
52.0%
-4964.8%
Net Margin
CKX
CKX
PLUR
PLUR
Q3 25
71.5%
Q2 25
118.5%
Q1 25
33.2%
-1439.6%
Q4 24
-1597.8%
Q3 24
31.6%
-1804.3%
Q2 24
55.0%
Q1 24
-282.9%
-7454.9%
Q4 23
-4671.4%
EPS (diluted)
CKX
CKX
PLUR
PLUR
Q3 25
$0.08
Q2 25
$0.08
Q1 25
$2027032.00
$-0.94
Q4 24
$-1991337.18
$-0.53
Q3 24
$0.03
$-1.08
Q2 24
$0.27
Q1 24
$1991337.00
$-1.01
Q4 23
$-0.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CKX
CKX
PLUR
PLUR
Cash + ST InvestmentsLiquidity on hand
$5.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.9M
$-6.8M
Total Assets
$19.2M
$38.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CKX
CKX
PLUR
PLUR
Q3 25
Q2 25
$5.9M
Q1 25
$8.5M
Q4 24
$7.2M
Q3 24
$3.2M
Q2 24
$6.8M
Q1 24
$7.1M
Q4 23
$5.5M
Stockholders' Equity
CKX
CKX
PLUR
PLUR
Q3 25
$18.9M
Q2 25
$18.7M
$-6.8M
Q1 25
$18.7M
$-4.5M
Q4 24
$18.6M
$-8.0M
Q3 24
$18.6M
$-5.3M
Q2 24
$18.5M
$96.0K
Q1 24
$18.0M
$-356.0K
Q4 23
$18.3M
$4.4M
Total Assets
CKX
CKX
PLUR
PLUR
Q3 25
$19.2M
Q2 25
$18.9M
$38.7M
Q1 25
$19.0M
$37.4M
Q4 24
$18.8M
$30.9M
Q3 24
$18.7M
$35.4M
Q2 24
$19.0M
$39.5M
Q1 24
$18.4M
$36.4M
Q4 23
$18.8M
$41.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CKX
CKX
PLUR
PLUR
Operating Cash FlowLast quarter
$242.3K
$-18.2M
Free Cash FlowOCF − Capex
$-19.8M
FCF MarginFCF / Revenue
-4982.2%
Capex IntensityCapex / Revenue
406.5%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$-33.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CKX
CKX
PLUR
PLUR
Q3 25
$242.3K
Q2 25
$-24.6K
$-18.2M
Q1 25
$118.7K
$-4.3M
Q4 24
$97.4K
$-4.6M
Q3 24
$-246.5K
$-4.1M
Q2 24
$691.7K
$-18.0M
Q1 24
$-337.8K
$-4.2M
Q4 23
$624.5K
$-3.6M
Free Cash Flow
CKX
CKX
PLUR
PLUR
Q3 25
Q2 25
$-19.8M
Q1 25
$-4.9M
Q4 24
$-4.7M
Q3 24
$-4.3M
Q2 24
$-18.3M
Q1 24
$-4.3M
Q4 23
$-3.8M
FCF Margin
CKX
CKX
PLUR
PLUR
Q3 25
Q2 25
-4982.2%
Q1 25
-1142.9%
Q4 24
-2562.2%
Q3 24
-1310.4%
Q2 24
-19108.3%
Q1 24
-6043.7%
Q4 23
-3590.5%
Capex Intensity
CKX
CKX
PLUR
PLUR
Q3 25
Q2 25
406.5%
Q1 25
135.1%
Q4 24
60.5%
Q3 24
63.8%
Q2 24
336.5%
Q1 24
125.4%
Q4 23
115.2%
Cash Conversion
CKX
CKX
PLUR
PLUR
Q3 25
1.46×
Q2 25
-0.15×
Q1 25
1.03×
Q4 24
Q3 24
-4.56×
Q2 24
1.22×
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons